Sign In
Buy TENX
$12.25
+0.250 (+2.08%)
At Close: Jun 22, 2026
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis have voluntarily agreed to step down from the Board of Directors.
Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update
04:45pm, Wednesday, 31'st Mar 2021
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX) today reported financial results for the year ended December 31, 2020 and provided a business update
Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
08:30am, Thursday, 04'th Mar 2021
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) to present company overview at H.C. Wainwright Global Life Sciences Virtual Conference held March 9-10, 2021
Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med
07:45am, Wednesday, 20'th Jan 2021
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX) to host conf. call & live audio webcast on Jan 21, 2021, at 4:30 pm to discuss acquisition of PH Precision Med
Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today
10:50am, Tuesday, 19'th Jan 2021
A slew of biopharma stocks are making big moves Tuesday on the back of clinical trial readouts as well announcements regarding M&A and tie-ups. Merus, Lilly In $1.68B Oncology Deal: Dutch-based Merus
TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket
10:47am, Tuesday, 19'th Jan 2021
Tenax Therapeutics (TENX) stock is flying high on Tuesday after announcing it has acquired biotech company PH Precision Med. The post TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Preci
Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med
07:45am, Tuesday, 19'th Jan 2021
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX) acquires PH Precision Med (PHPM), adding imatinib to its pipeline. Stuart Rich, MD joins as CMO.
